In this study, we aim to evaluate the diagnostic performance of PSMA-PET/mpMRI for local staging of de novo prostate cancer and to compare it directly with standalone mpMRI and PSMA-PET obtained from the same hybrid examination. The gene discussed is FOLH1; the disease is prostate carcinoma.